(Q33890074)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19889950%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

title

Should the PANSS be rescaled? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19889950%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19889950%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Florian Seemüller

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19889950%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

5

Hans-Jürgen Möller

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19889950%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

author name string

Michael Obermeier

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19889950%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Rebecca Schennach-Wolff

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19889950%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Michael Riedel

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19889950%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

language of work or name

English

0 references

publication date

4 November 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19889950%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

published in

Schizophrenia Bulletin

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19889950%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

volume

36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19889950%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19889950%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

page(s)

455-460

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19889950%20AND%20SRC:MED&resulttype=core&format=json

Definitions of response and remission in schizophrenia: recommendations for their use and their presentation

11 February 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2879676

Clozapine alone versus clozapine and risperidone with refractory schizophrenia

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2879676

Relationship between plasma risperidone and 9-hydroxyrisperidone concentrations and clinical response in patients with schizophrenia

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2879676

Risperidone in the treatment of patients with chronic schizophrenia: a multi-national, multi-centre, double-blind, parallel-group study versus haloperidol. Risperidone Study Group

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2879676

Risperidone in the treatment of schizophrenia

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2879676

The positive and negative syndrome scale (PANSS) for schizophrenia

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2879676

The clinical relevance of percentage improvements on the PANSS score.

5 July 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBP124

Increased plasma brain-derived neurotropic factor, not nerve growth factor-Beta, in schizophrenia patients with better response to risperidone treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBP124

Ziprasidone vs clozapine in schizophrenia patients refractory to multiple antipsychotic treatments: the MOZART study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBP124

A double-blind, placebo-controlled dose-response comparison of intramuscular olanzapine and haloperidol in the treatment of acute agitation in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FSCHBUL%2FSBP124

Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2879676

Risperidone treatment of outpatients with schizophrenia: no evidence of sex differences in treatment response

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2879676

Retention rates in placebo- and nonplacebo-controlled clinical trials of schizophrenia.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2879676

Defining 'response' in antipsychotic drug trials: recommendations for the use of scale-derived cutoffs

29 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19889950

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1093/SCHBUL/SBP124

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19889950%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19889950%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

PubMed publication ID

19889950

1 reference